DMD外显子45-55缺失中的抗肌萎缩蛋白病表型与修饰因素
这项横断面多中心队列研究纳入57例DMD外显子45-55缺失者,评估其表型与修饰因素,发现28%表现为Becker表型、19%为孤立性心脏病、53%无症状,90%儿童存在认知障碍,仅LTBP4单体型与心脏病相关,表型变异机制仍未明确。
要点
- DMD外显子45-55缺失者中53%无症状、28%为Becker表型、19%为孤立性心脏病。
- 90%的儿童存在认知障碍,表型按10个不同断点分类,其中4个为复发性。
- 所有9例肌肉活检抗肌萎缩蛋白表达均>67%,仅LTBP4单体型与心脏病相关。
核心结论
- 外显子45-55缺失可分离出高比例良性表型、严重病例及孤立性心脏和认知表现。
- 内含子断点位置和LTBP4修饰因素可能有一定影响,但表型变异的致病机制仍大部分未解决。
研究设计与样本
- 横断面、多中心队列研究,共57例受试者(其中23例为先证者)。
- 采用临床和功能评估,并用下一代测序鉴定内含子断点及其对Dp140启动子、内含子长非编码RNA和调控剪接序列的影响。
- 评估DMD修饰基因(SPP1、LTBP4、ACTN3)和伴随突变,并用DMD单核苷酸多态性构建单体型。
- 对9例肌肉活检通过免疫染色、蛋白质印迹、逆转录聚合酶链反应(PCR)和微滴数字PCR评估抗肌萎缩蛋白表达。
主要发现
- 57例受试者中Becker表型占28%、孤立性心脏病占19%、无症状特征占53%。
- 90%的儿童出现认知障碍。
- 患者按10个不同的先证者断点分类,其中4个因奠基者事件而复发。
- 特定断点(D5)与严重性相关,但因内含子序列变化未观察到显著影响。
- 所有活检显示抗肌萎缩蛋白表达>67%,并可见替代性del45-57转录本痕迹,但未认为具有致病相关性。
局限性
- 表型变异的致病机制仍大部分未解决。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Duchenne muscular dystrophy (DMD) exon 45-55 deletion (del45-55) has been postulated as a model that could treat up to 60% of DMD patients, but the associated clinical variability and complications require clarification. We aimed to understand the phenotypes and potential modifying factors of this dystrophinopathy subset. METHODS: This cross-sectional, multicenter cohort study applied clinical and functional evaluation. Next generation sequencing was employed to identify intronic breakpoints and their impact on the Dp140 promotor, intronic long noncoding RNA, and regulatory splicing sequences. DMD modifiers (SPP1, LTBP4, ACTN3) and concomitant mutations were also assessed. Haplotypes were built using DMD single nucleotide polymorphisms. Dystrophin expression was evaluated via immunostaining, Western blotting, reverse transcription polymerase chain reaction (PCR), and droplet digital PCR in 9 muscle biopsies. RESULTS: The series comprised 57 subjects (23 index) expressing Becker phenotype (28%), isolated cardiopathy (19%), and asymptomatic features (53%). Cognitive impairment occurred in 90% of children. Patients were classified according to 10 distinct index-case breakpoints; 4 of them were recurrent due to founder events. A specific breakpoint (D5) was associated with severity, but no significant effect was appreciated due to the changes in intronic sequences. All biopsies showed dystrophin expression of >67% and traces of alternative del45-57 transcript that were not deemed pathogenically relevant. Only the LTBP4 haplotype appeared associated the presence of cardiopathy among the explored extragenic factors. INTERPRETATION: We confirmed that del45-55 segregates a high proportion of benign phenotypes, severe cases, and isolated cardiac and cognitive presentations. Although some influence of the intronic breakpoint position and the LTBP4 modifier may exist, the pathomechanisms responsible for the phenotypic variability remain largely unresolved. ANN NEUROL 2022;92:793-806.
引用
- Poyatos-García J, Martí P, Liquori A, et al. Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45-55 Deletion. Ann Neurol. 2022. PMID: 35897138. doi:10.1002/ana.26461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。